KALA BIO Statistics

Total Valuation

KALA BIO has a market cap or net worth of $27.29 million. The enterprise value is $15.13 million.

Market Cap	27.29M
Enterprise Value	15.13M

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

KALA BIO has 4.61 million shares outstanding. The number of shares has increased by 53.04% in one year.

Current Share Class	4.61M
Shares Outstanding	4.61M
Shares Change (YoY)	+53.04%
Shares Change (QoQ)	+52.71%
Owned by Insiders (%)	3.91%
Owned by Institutions (%)	16.87%
Float	2.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.98
P/TBV Ratio	3.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.15, with a Debt / Equity ratio of 5.40.

Current Ratio	2.15
Quick Ratio	2.06
Debt / Equity	5.40
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.88

Financial Efficiency

Return on equity (ROE) is -430.96% and return on invested capital (ROIC) is -55.26%.

Return on Equity (ROE)	-430.96%
Return on Assets (ROA)	-43.75%
Return on Capital (ROIC)	-55.26%
Revenue Per Employee	n/a
Profits Per Employee	-$906,116
Employee Count	43
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.45% in the last 52 weeks. The beta is -2.14, so KALA BIO's price volatility has been lower than the market average.

Beta (5Y)	-2.14
52-Week Price Change	-13.45%
50-Day Moving Average	6.42
200-Day Moving Average	6.50
Relative Strength Index (RSI)	41.69
Average Volume (20 Days)	31,304

Short Selling Information

The latest short interest is 26,310, so 0.57% of the outstanding shares have been sold short.

Short Interest	26,310
Short Previous Month	30,475
Short % of Shares Out	0.57%
Short % of Float	0.94%
Short Ratio (days to cover)	1.91

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-40.32M
Pretax Income	-38.72M
Net Income	-38.96M
EBITDA	-40.06M
EBIT	-40.32M
Earnings Per Share (EPS)	-$11.81

Full Income Statement

Balance Sheet

The company has $49.20 million in cash and $37.04 million in debt, giving a net cash position of $12.16 million or $2.64 per share.

Cash & Cash Equivalents	49.20M
Total Debt	37.04M
Net Cash	12.16M
Net Cash Per Share	$2.64
Equity (Book Value)	6.86M
Book Value Per Share	1.49
Working Capital	27.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$32.48 million and capital expenditures -$146,000, giving a free cash flow of -$32.63 million.

Operating Cash Flow	-32.48M
Capital Expenditures	-146,000
Free Cash Flow	-32.63M
FCF Per Share	-$7.08

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KALA BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.04%
Shareholder Yield	-53.04%
Earnings Yield	-142.76%
FCF Yield	-119.54%

Analyst Forecast

The average price target for KALA BIO is $15.00, which is 153.38% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	153.38%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 21, 2022. It was a reverse split with a ratio of 0.02:1.

Last Split Date	Oct 21, 2022
Split Type	Reverse
Split Ratio	0.02:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2